The Department does not have information on the market share in financial terms of each supplier.
Influenza vaccines are supplied direct to the national health service by Wyeth Pharmaceuticals, Sanofi Pasteur MSD, Solvay, Chiron Vaccines, GlaxoSmithKline and MASTA. Hepatitis B vaccine is supplied direct to the NHS by Sanofi Pasteur MSD and GlaxoSmithKline.
The information on market share for these products is commercially confidential.
Prior to September 2004, oral polio vaccine (OPV) was used in the routine national childhood immunisation programme. GlaxoSmithKline was the sole supplier of this product in the United Kingdom from November 2000. From September 2004 onwards, the UK replaced OPV with inactivated polio vaccine (IPV). IPV is provided as one component of the combined vaccines used for protecting against polio and other diseases. These vaccines are supplied by Sanofi Pasteur MSD and GlaxoSmithKline.